- Location
gene therapy
"-
The Project Is The Result of an Initiative of Spanish People
Feb 7, 2014The project is the result of an initiative of Spanish people affected by this rare disease. FARA, one of the main patients' associations in the United States now joins the endeavour The gene therapy-based research project to tackle ...
Tags: FARA, CBMSO, GENEFA Platform, IRB
-
A New Gene Therapy Could Prove Key to Preventing More Common Inherited Causes of Blindness
Jan 16, 2014A new gene therapy that successfully treated a rare eye disease in clinical trials could prove the key to preventing more common inherited causes of blindness, researchers say. In six male patients, doctors used a virus to repair a ...
-
Preliminary Treatment Appears Effective to Control Motor Function in Parkinson's Disease
Jan 13, 2014A new, preliminary treatment involving triple-gene therapy appears safe and effective in helping to control motor function in Parkinson's disease patients, according to new research. The therapy, called ProSavin, works by reprogramming ...
-
Gene Therapy Might Be a Powerful Weapon Against Leukemia and Other Blood Cancers
Dec 26, 2013Preliminary research shows that gene therapy might one day be a powerful weapon against leukemia and other blood cancers. The experimental treatment coaxed certain blood cells into targeting and destroying cancer cells, according to ...
Tags: gene therapy, leukemia, blood cancer
-
VBL Therapeutics Has Secured Fast Track Status From The US FDA
Nov 29, 2013VBL Therapeutics has secured fast track status from the US Food and Drug Administration (FDA) for its lead oncology drug VB-111, for prolongation of survival in patients with Recurrent Glioblastoma Multiforme (rGBM). VB-111 was already ...
-
Editas Medicine Announced It Has Secured a $43m Series a Financing
Nov 27, 2013Editas Medicine, a transformative genome editing company, today announced it has secured a $43m Series A financing led by Flagship Ventures, Polaris Partners and Third Rock Ventures with participation from Partners Innovation Fund. ...
Tags: Editas Medicine, genome editing
-
Nuvilex Has Acquired The Exclusive Worldwide Rights
Nov 12, 2013Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, has acquired the exclusive worldwide rights to use the cellulose-based live-cell encapsulation technology for the ...
Tags: Nuvilex, Live-Cell Encapsulation Technology, biotechnology, cell, gene
-
A Gene Therapy Company Focused on Developing Novel Treatments for Rare Diseases
Nov 4, 2013Fidelity Biosciences, a subsidiary of Fidelity Investments, and US-based Regenx Biosciences have announced the formation of Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases. Dimension ...
Tags: Biosciences, Health, Medicine
-
Veritas Bio Received a Patent Related to in Vivo Delivery of Nucleic Acids
Sep 13, 2013US-based biotechnology company Veritas Bio received a patent related to in vivo delivery of nucleic acids from the European Patent Office. Inventor Dr Pachuk noted the allowed claims cover transfecting nucleic acids into skin or muscle ...
-
A Duchenne Muscular Dystrophy Boy's Parents Are Hoping Sales of a Product They Invented
Apr 2, 2013The parents of a Naperville boy with Duchenne muscular dystrophy are hoping sales of a product they invented and recently launched will help provide research funds and renewed hope for him and others with the rare disorder. Marty and Geri ...
Tags: toy
-
Bluebird Bio Has Formed a Broad Collaboration with Celgene
Mar 26, 2013Biotechnology company bluebird bio has formed a broad collaboration with Celgene to develop new disease-altering gene therapies in oncology. The multi-year research and development collaboration aims to apply gene therapy technology to ...
-
Parkinson's Disease: Study Could Be Diagnosed by Testing Saliva
Jan 15, 2013New research from Mayo Clinic and Banner Sun Health Research Institute has demonstrated that testing a portion of saliva gland could be a way to diagnose Parkinson's disease. The study, which enrolled 15-patient, collected biopsies from ...
-
USPTO Has Granted a Noa to Sanovas' Nested Balloon Catheter for Localized Drug Delivery
Dec 18, 2012The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Sanovas' minimally invasive nested balloon catheter for localized drug delivery. The patent will protect an integral part of the company's NanoVas ...
Tags: USPTO, NOA, minimally invasive nested balloon catheter, medical product
-
Orphan Drug Designation to Milo Biotechnology's Aav1-Fs344 Has Been Granted by The Us Fda
Dec 14, 2012The US FDA has granted orphan drug designation to Milo Biotechnology's AAV1-FS344 to treat Becker and Duchenne muscular dystrophy. AAV1-FS344 is myostatin inhibitor delivered through gene therapy to increase muscle strength in patients. ...
Tags: FDA, orphan drug designation, US
-
Hemophilia B Gene Therapy Treatment Be Developed by Baxter and Chatham Partner
Nov 28, 2012Baxter International has collaborated with Chatham Therapeutics for the development and commercialization of factor IX hemophilia B gene therapy treatment. According to the agreement, the companies will investigate the next generation of ...
Tags: IX hemophilia B gene therapy, Biological Nano Particles, clinical trials
Related Products
-
2023European Beauty Therapy Anti-Aging Allsensa Biological Gene Peptide Mesotherapy Skin Booster Solves Eye Aging Problems Such as Eye Bags, Dark Circles
-
ISO Class 8 Dust Free Modular Cell and Gene Therapy GMP Clean Room
-
European Beauty Therapy Anti-Aging Allsensa Biological Gene Peptide Mesotherapy Skin Booster Solves Eye Aging Problems Such as Eye Bags, Dark Circles, Eye Wrink
